Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro
- PMID: 284362
- PMCID: PMC382963
- DOI: 10.1073/pnas.76.1.473
Incorporation of glucocerebrosidase into Gaucher's disease monocytes in vitro
Abstract
Several carriers were evaluated for use in the delivery of exogenous glucocerebrosidase to monocytes from Gaucher's disease patients. Only gamma globulin-coated, resealed erythrocytes proved to be an effective vehicle for enzyme delivery. Glucocerebrosidase added in this manner normalized intracellular enzyme levels for at least 18 hr. In this model system for the study of enzyme replacement therapy, soluble enzyme, enzyme in uncoated resealed erythrocytes, and enzyme incorporated into liposomes were ineffective.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
